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Introduction
Modulation of microtubule (MT) dynamics and reorganization 
of the MT cytoskeleton are key events accompanying cellu-
lar morphogenesis during differentiation and tissue remodel-
ing (Gierke and Wittmann, 2012). This change in cytoskeletal 
organization and dynamics is often mediated by an evolution-
arily conserved mechanism involving capture of MT plus ends 
by cortical factors that favor local MT stabilization (Gundersen, 
2002; Wu et al., 2006). We showed that, in epithelial cells, the 
kinesin-2 family motor KIF17 associates with MT plus ends 
via an interaction with the EB1 (end-binding protein 1). We 
also demonstrated that KIF17 dampens MT dynamics, contrib-
utes to MT stabilization, and is necessary for polarization of 
epithelial cells in 3D matrices. We proposed that active KIF17 
could participate in regulating interactions of MT plus ends and 
cortical proteins during MT capture and stabilization (Jaulin 
and Kreitzer, 2010). However, how KIF17 activity is regulated 
temporally and spatially to contribute to MT dynamics and epi-
thelial polarization is not known.
Kinesins are MT-stimulated mechanoenzymes that use 
ATP hydrolysis to generate motile forces (Schliwa and Woehlke, 
2003; Vale, 2003). Several kinesins, including KIF17, are regu-
lated by an autoinhibitory mechanism wherein the motor and 
tail domains interact, resulting in reduced MT binding and/or ADP 
release (Coy et al., 1999; Hackney and Stock, 2000; Imanishi 
et al., 2006; Dietrich et al., 2008; Verhey and Hammond, 2009; 
Hammond et al., 2010; Jaulin and Kreitzer, 2010). To understand 
how KIF17 is regulated in epithelial cells for MT stabiliza-
tion, we designed kinesin biosensor constructs that are moni-
tored using fluorescence lifetime imaging microscopy (FLIM). 
These biosensors provide a readout of kinesin conformation 
based on measurements of intramolecular Förster resonance 
energy transfer (FRET) efficiency (Wallrabe and Periasamy, 
2005); inactive motors in a compact conformation generate 
FRET, whereas active motors in an extended conformation do 
not. FRET-based, sensitized emission approaches have been 
used in live cells to detect kinesin-1 and kinesin-3 in com-
pact and extended conformations (Cai et al., 2007; Hammond 
et al., 2009). However, quantitative determination of active 
and inactive kinesin populations and their spatial distributions 
cannot be resolved with this approach. By comparison, FLIM 
improves sensitivity, is quantitative, and allows independent 
determinations of FRET efficiency and the fraction of interact-
ing donor molecules (Piston and Kremers, 2007; Padilla-Parra 
and Tramier, 2012). Here, we apply phasor analysis to FLIM 
(Clayton et al., 2004; Redford and Clegg, 2005; Caiolfa et al., 
2007; Digman et al., 2008), allowing us to localize active and 
inactive kinesin populations in single cells for the first time 
across large datasets.
We showed previously that the kinesin-2 motor KIF17 regulates microtubule (MT) dynamics and organization to promote epithelial dif-
ferentiation. How KIF17 activity is regulated during this 
process remains unclear. Several kinesins, including KIF17, 
adopt compact and extended conformations that reflect 
autoinhibited and active states, respectively. We designed 
biosensors of KIF17 to monitor its activity directly in single 
cells using fluorescence lifetime imaging to detect Förster 
resonance energy transfer. Lifetime data are mapped on 
a phasor plot, allowing us to resolve populations of active 
and inactive motors in individual cells. Using this bio-
sensor, we demonstrate that PKC contributes to the ac-
tivation of KIF17 and that this is required for KIF17 to 
stabilize MTs in epithelia. Furthermore, we show that EB1 
recruits KIF17 to dynamic MTs, enabling its accumulation 
at MT ends and thus promoting MT stabilization at dis-
crete cellular domains.
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compact (FRET signal) and extended (non-FRET) populations 
of mCh-KIF17-EmGFP. To discriminate between these two popu-
lations, we mapped the spatial distribution of FRET and non-
FRET species in cells using phasor analysis. Based on our FRET 
confidence limit (see Materials and methods), pixels in the image 
with FRETeff ≤ 7% represent KIF17 in an extended conforma-
tion, whereas pixels with FRETeff = 7–21% represent KIF17 in 
a compact form (Fig. 1 B, phasor plot). Phasor analysis revealed 
that 64.9 ± 2.0% of mCh-KIF17-EmGFP is in a compact state 
(Fig. 1 D). This pool of mCh-KIF17-EmGFP localizes through-
out the cytoplasm but does not generally extend to the cell periph-
ery (Fig. 1 B, green mask). A smaller but significant proportion 
(25.9 ± 1.4%) of mCh-KIF17-EmGFP was in the extended con-
formation (Fig. 1 D) and localized prominently near the cell pe-
riphery (Fig. 1 B, red mask). The cortical distribution of extended 
KIF17 is consistent with the EB1-dependent localization of 
endogenous protein to MT plus ends and a role in plus end–
 mediated MT stabilization (Jaulin and Kreitzer, 2010). It is likely 
that some extended KIF17 is also located on more central MTs, 
but this pool is obscured in our analysis by the greater cell depth 
and larger fraction of motor in the compact form in these regions. 
Extended KIF17 was also detected above/below nuclei, where 
the cytoplasmic depth is narrow, and compact KIF17 did not 
obscure detection of an extended motor.
To confirm that the KIF17 we detect in an extended confor-
mation represents the population of KIF17 on MTs, we permeabi-
lized living cells in the presence of AMP-PNP, a nonhydrolyzable 
ATP analogue that recruits kinesins to MTs (Lasek and Brady, 
1985). Under these conditions, mCh-KIF17-EmGFP EAV de-
creased 65%, with a corresponding 2.3-fold increase in KIF17 
in an extended form (Fig. S1, D and E; and Table 1), consistent 
with previous studies (Hammond et al., 2010). Thus, KIF17 in an 
open conformation by FRET represents the population of motor 
on MTs.
To verify that different KIF17 conformations detected 
with FRET reflect motor activity, we next analyzed the con-
stitutively active hinge mutant mCh-KIF17G754E-EmGFP. The 
FRET efficiency of mCh-KIF17G754E-EmGFP was 66% less 
than that of mCh-KIF17-EmGFP (EAV = 2.3 ± 0.6%; Fig. 1 D  
and Table 1). Phasor analysis showed that 70.1 ± 4.0% of 
KIF17G754E is in an extended conformation, a 2.7-fold increase 
as compared with KIF17; only 13.8 ± 2.0% of KIF17G754E is 
detected in a compact conformation (Fig. 1 D and Table 1). 
Conformationally extended mCh-KIF17G754E-EmGFP localized 
throughout the cell and accumulated at MT plus ends in cell 
protrusions (Fig. 1 C, red mask and inset grayscale image), as 
shown previously for GFP-KIF17G754E (Jaulin and Kreitzer, 
2010). Some FRET was detected in these protrusions (Fig. 1 C, 
green mask) and likely arises from crowding-induced intermo-
lecular interactions rather than motors in a folded state, as sug-
gested previously for kinesin-1 (Cai et al., 2007).
Further evidence that KIF17 conformation reflects its 
activity comes from data showing that KIF17 motor and tail 
domains interact and that full-length KIF17 is not efficient for 
MT-based motility but that removal of the C-terminal tail or 
mutation of the hinge produces a motor that moves effec-
tively on MTs (Imanishi et al., 2006; Hammond et al., 2010; Jaulin 
Using a KIF17 biosensor, we provide direct evidence that 
KIF17 conformation and activity are regulated by EB1 and PKC. 
Our data suggest that PKC activates KIF17 for binding to dy-
namic MTs and that EB1 promotes KIF17 accumulation in an 
active form at the ends of dynamic MTs. Both EB1 and active 
PKC affect KIF17 conformation in cells and are likely to con-
tribute to selective MT stabilization by KIF17 in epithelia. The 
data presented here provide the first direct visualization of 
extended, active and compact, inactive kinesin populations 
in living cells and demonstrate that conformational biosensors 
monitored by FLIM, combined with phasor analysis of lifetime 
data, provide a significant technical advance over current ap-
proaches to study kinesin regulation in living cells.
Results and discussion
Active KIF17 in an extended conformation 
localizes at the cell periphery in MDCK 
epithelial cells
We and others have shown that KIF17 undergoes a salt-dependent 
change in conformation in vitro (Imanishi et al., 2006; Hammond 
et al., 2010; Jaulin and Kreitzer, 2010). To detect KIF17 confor-
mations in cells directly, we designed intramolecular FRET 
expression constructs encoding full-length KIF17 tagged with 
mCherry (mCh) and Emerald GFP (EmGFP) at N and C termini, 
respectively. We used FLIM to measure the decay in EmGFP life-
time caused by quenching by mCh in live MDCK cells (Bastiaens 
and Squire, 1999). In all experiments, donor lifetimes in cells 
expressing FRET constructs (mCh-KIF17-EmGFP) were refer-
enced to cells expressing donor alone (KIF17-EmGFP). Only 
cells with low to medium expression levels were chosen for analy-
sis to avoid artifacts caused by overexpression. Lifetime data 
were analyzed using the phasor approach. This method is amena-
ble to rapid analysis of a large number of cells and reports the lo-
calization of kinesin populations in compact and extended states 
in the cell as well as the relative amount of each population (see 
Materials and methods and Fig. S1 [B and C] for details).
We first determined that N- and C-terminal tags did not 
interfere with KIF17 function by testing whether FRET constructs 
stabilized MTs when expressed in MDCK cells, as described pre-
viously for the constitutively active, extended conformation 
hinge mutant GFP-KIF17G754E (Jaulin and Kreitzer, 2010). In 
cells expressing mCh-KIF17-EmGFP, KIF17-EmGFP, GFP-
KIF17, or mCh-KIF17G754E-EmGFP, we observed an increase in 
nocodazole (NZ)-resistant, posttranslationally modified (dety-
rosinated or acetylated) stable MTs (Fig. 1, A and E; and not 
depicted). Thus, fluorescently tagged wild-type and mutant KIF17 
are active for MT stabilization, demonstrating that these con-
structs are functional in cells.
As shown previously for GFP-KIF17 (Jaulin and Kreitzer, 
2010), exogenously expressed mCh-KIF17-EmGFP appeared 
primarily as diffuse cytoplasmic fluorescence (Fig. 1 B, inset 
grayscale image), suggesting that the majority of KIF17 is 
in a compact, inactive conformation as previously described 
(Hammond et al., 2010). Using FLIM, we measured a mean FRET 
efficiency (EAV) for mCh-KIF17-EmGFP of 6.8 ± 0.2% (Fig. 1 D 
and Table 1). However, this mean could reflect a mixture of both 
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Figure 1. Localization of active and inactive populations of KIF17 in MDCK cells. (A) Immunostaining of tyrosinated and detyrosinated tubulin in cells 
microinjected with mCh-KIF17-EmGFP (outlined cells and inset) and treated for 45 min with 33 µM NZ. (B) Representative FLIM phasor analysis of 
mCh-KIF17-EmGFP in cells. Fluorescence image (inset) and the distribution of KIF17 in extended, active (red mask on image and red circle on phasor plot, 
FRETeff < 7%) and compact, inactive (green mask on image and green circle on phasor plot, FRETeff = 7–21%) forms determined from measured lifetimes. 
Inset on the phasor plot shows analysis of mCh-KIF17G754E-EmGFP. (C) Representative FLIM phasor analysis of mCh-KIF17G754E-EmGFP in cells as in B. 
(D) Box–whisker plots showing the distribution of FRETeff and populations of active and inactive mCh-KIF17-EmGFP and mCh-KIF17G754E-EmGFP in in MDCK 
cells. Data represent the indicated number of cells (n) obtained from three or more independent experiments ± SEM. Box–whisker plots show minimum, 25th 
percentile, median, 75th percentile, maximum, and mean FRET values. (E) Quantification of immunoblots probed for detyrosinated (Glu) and acetylated 
(Ace) tubulin in control or mCh-KIF17-EmGFP transfected cells. Ratio of tubulin/actin was normalized to 1 ± SD in controls. Data are derived from five 
experiments. Bars, 20 µm.
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Because KIF17 may act through this pathway (Jaulin and 
Kreitzer, 2010), we tested whether PKC affects KIF17 confor-
mation and activity for MT stabilization. We treated MDCK 
cells expressing mCh-KIF17-EmGFP with the PKC inhibitor 
BIM-1 (bisindolylmaleimide I; 20 µM) for 1 h (Fig. 2); at this 
concentration, classical PKCs  and I and novel PKCs  and  
are likely inhibited (Martiny-Baron et al., 1993).
BIM-1 induced a 20% increase over controls in EAV 
of mCh-KIF17-EmGFP and a 41% decrease in the extended 
population of KIF17 (Fig. 2, A and B; and Table 1). Further-
more, BIM-1–treated cells expressing mCh-KIF17-EmGFP 
(or KIF17-EmGFP) failed to generate NZ-resistant, stable MTs 
(Fig. 2 C). These data implicate PKC in regulating KIF17 con-
formation and thus its ability to interact with and stabilize MTs 
in cells. Inhibition of PKC could alternatively prevent genera-
tion of stable MTs by affecting downstream components in 
the MT stabilization pathway (e.g., GSK3-), as suggested in 
fibroblasts (Eng et al., 2006); this could inhibit KIF17 activity 
indirectly by affecting its binding to and unfolding on MTs. 
However, BIM-1 alone had no effect on levels of posttrans-
lationally modified, stable MTs in MDCK cells (unpublished 
data). Furthermore, pretreatment of cells with BIM-1 did not 
affect the localization of the extended mutant GFP-KIF17G754E 
at MT ends in cell protrusions (Fig. 2 D) or its ability to sta-
bilize MTs (not depicted). Considered together, these data 
support a model in which active PKC releases KIF17 autoinhi-
bition, promoting binding to and stabilization of MTs. KIF17 
and Kreitzer, 2010). Similarly, recombinant OSM-3, the Cae-
norhabditis elegans homologue of KIF17, has little to no motil-
ity in vitro, but both a hinge mutant and C-terminally truncated 
OSM-3 move efficiently on MTs (Imanishi et al., 2006; Hammond 
et al., 2010; Jaulin and Kreitzer, 2010). Here, using purified 
recombinant protein, we found that the KIF17 tail domain 
(amino acids 850–1,029) ablates MT gliding and inhibits MT-
stimulated ATPase activity in vitro of C-terminally truncated 
KIF17 (amino acids 1–490, KIF17M-490; Fig. S1 A and Table 2). 
In these assays, KIF17M-490 had a maximal MT-stimulated 
ATPase rate (kcat) of 13.6 ± 1.8 s1, which decreased to 3.9 ± 
0.7 s1 in the presence of the KIF17 tail domain. Interestingly, 
addition of KIF17 tail also decreases K0.5, MT of KIF17M-490, 
suggesting that functional inhibition of motor activity is not 
necessarily caused by displacement of the kinesin from MTs 
(Dietrich et al., 2008; Acharya et al., 2013). From these and 
previous studies we conclude the FRET conformation sensor is 
an accurate reporter of active (extended) and inactive (compact) 
KIF17 in living cells.
PKC activity is necessary to relieve  
KIF17 autoinhibition and activate it  
for MT stabilization
PKC family members have been implicated in regulation of MT 
dynamics and polarization of several cell types and act in the 
cortical MT capture and stabilization pathway (Kabir et al., 
2001; Fan et al., 2004; Ruiz-Canada et al., 2004; Eng et al., 2006). 
Table 1. Summary of FRET efficiencies and percentage of active, extended KIF17 measured under all conditions described
Expressions Treatments EAV P-value Active pool P-value
% %
mCh-KIF17-EmGFP Untreated 6.8 ± 0.2 NA 25.9 ± 1.4 NA
mCh-KIF17-EmGFP 1 mM AMP-PNP 2.4 ± 0.9 <0.001a 58.4 ± 4.8 <0.001a
mCh-KIF17G754E-EmGFP Untreated 2.3 ± 0.6 <0.001a 70.1 ± 4.0 <0.001a
mCh-KIF17-EmGFP 33 µM NZ 7.0 ± 0.4 >0.5a 25.9 ± 3.7 >0.5a
mCh-KIF17-EmGFP Cold + 33 µM NZ 9.7 ± 0.5 <0.001a 15.2 ± 3.5 <0.001a
mCh-KIF17-EmGFP 100 nM OA 7.8 ± 0.4 <0.05a 15.9 ± 2.6 <0.005a
mCh-KIF17-EmGFP 10 µM taxol 9.3 ± 0.6 <0.001a 11.4 ± 2.5 <0.001a
mCh-KIF17-EmGFP 20 µM BIM-1 8.5 ± 0.5 <0.001a 14.6 ± 1.7 <0.001a
mCh-KIF17-EmGFP + Myc-EB1 Untreated 5.4 ± 0.4 <0.001a 40.2 ± 4.3 <0.001a
mCh-KIF17-EmGFP + Myc-EB1 33 µM NZ 6.7 ± 0.5 <0.005 b 24.2 ± 3.9 <0.001b
mCh-KIF17-EmGFP + Myc-EB1 Cold + 33 µM NZ 8.5 ± 0.6 <0.001b 16.3 ± 1.8 <0.001b
NA, not applicable.
aValue distribution as compared with mCh-KIF17-EmGFP using a two-tailed Student’s t test.
bValue distribution as compared with mCh-KIF17-EmGFP + Myc-EB1 using a two-tailed Student’s t test.
Table 2. ATPase properties of KIF17M-490
Constructs ATPase activity Gliding
kcat K0.5, MT Velocity Motile MT No. of MT observed
s1 µM µm/s %
KIF17 M-490 13.6 ± 1.8 1.3 ± 0.1 0.47 ± 0.02 11.6 ± 0.9 247
KIF17 M-490 + KIF17-tail 3.9 ± 0.7 0.4 ± 0.3 ND ND 252
KIF17 M-490 + EB1 16.6 ± 1.2 0.7 ± 0.3 0.51 ± 0.03 16.6 ± 1.3 251
ATPase activity of KIF17M-490 in the absence and presence of KIF17-tail or EB1. Data (Fig. S1 A) were fit to a Michaelis–Menton equation to determine kcat and K0.5, MT. 
Data represent the mean of nine independent experiments at three different MT concentrations ± SEM. kcat refers to the rate of ATP hydrolysis per kinesin dimer. K0.5, MT 
refers to the concentration of polymerized tubulin to half-maximally stimulate ATPase activity. Errors are ± SEM.
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in cortical MT stabilization, is dependent on EB1 but that mutant 
KIF17G754E accumulates at plus ends and stabilizes MTs indepen-
dent of EB1 (Jaulin and Kreitzer, 2010). This led us to speculate 
that EB1 binding to KIF17 at MT ends could either activate the 
motor for MT stabilization or enhance its accumulation in an 
active form at MT ends. To test this directly, we coexpressed 
mCh-KIF17-EmGFP and Myc-EB1 in MDCK cells and ana-
lyzed KIF17 conformation with FLIM (Fig. 3). In these experi-
ments, EB1 coexpression resulted in a 20% decrease in EAV as 
contains several predicted PKC phosphorylation sites and thus 
could be regulated directly by PKC. Alternatively, PKC could 
affect KIF17 binding to a cargo that would activate the motor 
in cells (Verhey and Hammond, 2009).
EB1 keeps KIF17 in an active form at  
MT plus ends in MDCK cells
We showed previously that localization of endogenous KIF17 
to MT plus ends in epithelial cells, where it could participate 
Figure 2. PKC activity is required for KIF17 activation in MDCK cells. (A) Box–whisker plots showing the distribution of FRETeff (left) and the fraction of active 
KIF17 (right) in control and 20 µM BIM-1–treated cells (1 h). Data were obtained from at least three independent experiments ± SEM. Box–whisker plots 
show minimum, 25th percentile, median, 75th percentile, maximum, and mean FRET values. (B) Immunostaining of detyrosinated and tyrosinated tubulin 
in cells expressing mCh-KIF17-EmGFP after cDNA injection (outlined cells and inset) and treatment with BIM-1 as in A. Bars, 10 µm. (C) GFP-KIF17G754E 
localizes at the plus ends of MTs in cell protrusions (arrows) in control and BIM-1–treated cells as in B. Cells were fixed 2 h after cDNA microinjection. Inj, 
injection. Bars, 20 µm.
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Figure 3. Coexpression of EB1 increases the pool of extended, active KIF17 in MDCK cells. (A) Fluorescence images of mCh-KIF17-EmGFP expressed 
alone or with Myc-EB1. Red mask shows the localization of active mCh-KIF17-EmGFP. Bar, 20 µm. (B and D) Box–whisker plots showing the distribution 
of FRETeff under each experimental condition. (C and E) Box–whisker plots showing the fraction of active KIF17 under each experimental condition. Data 
were obtained from at least three independent experiments ± SEM. Box–whisker plots show minimum, 25th percentile, median, 75th percentile, maximum, 
and mean FRET values.
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Kreitzer, 2010), suggesting that active KIF17 is on stable MTs. 
To determine whether extended KIF17 localizes on a specific 
subset of MTs, we analyzed mCh-KIF17-EmGFP by FLIM 
when only dynamic MTs or both dynamic and stable MTs were 
depolymerized. Depolymerization of dynamic MTs had no ef-
fect on EAV or on the fraction of extended conformation mCh-
KIF17-EmGFP as compared with untreated controls (Fig. 4, 
A and B). However, when both dynamic and stable MTs were 
depolymerized, we measured a 30% increase in EAV accompa-
nied by a 43% decrease in the extended population of KIF17 
when compared with control untreated cells (Fig. 4, A and B). 
To break down stable, modified MTs selectively, we treated 
cells expressing mCh-KIF17-EmGFP with 100 nM okadaic 
acid (OA) for 90 min (Fig. S2 A; Gurland and Gundersen, 
1993). OA induced a 42% decrease in the extended population 
of KIF17 to 15.9 ± 2.6% (Fig. S2, B and C), similar to what we 
observed in cells treated with cold and NZ. Although OA de-
polymerizes stable, modified MTs preferentially in MDCK 
cells, we cannot yet exclude the possibility that it affects KIF17 
conformation and activity by modifying phosphorylation of the 
kinesin directly or of another factor that modulates KIF17 activity 
in our cells.
These experiments show that extended KIF17 resides 
primarily on stable MTs in MDCK cells. As such, we reasoned 
that stabilizing MTs with taxol (10 µM for 1 h) should lead 
to an increase in the pool of active, extended mCh-KIF17-
EmGFP. Surprisingly, we instead measured a 37% increase in 
EAV and a corresponding 56% decrease in the extended pool of 
KIF17 after taxol treatment (Fig. 4, A and B), similar to what 
was observed in cold and NZ-treated cells. The extended pool 
of mCh-KIF17-EmGFP was also reduced in cells treated with 
50 nM taxol for 1 h, thus the decrease in extended kinesin is not 
a result of MT bundling induced by high concentrations of the 
drug (unpublished data). Interestingly, KIF17G754E is lost from 
MT ends in cell protrusions when cells are treated with taxol, 
either before or after it was expressed acutely by cDNA injection 
compared with control cells expressing KIF17 alone (Fig. 3 B 
and Table 1). Phasor analysis showed this change in FRET effi-
ciency corresponded to a 55% increase in the population of ex-
tended KIF17 when EB1 was coexpressed (Fig. 3 C and Table 1).
When cells coexpressing EB1 and KIF17 are treated with 
33 µM NZ for 45 min to depolymerize dynamic MTs (note that 
some stable, modified MTs remain even in uninjected cells; 
Fig. 1 A), the population of extended KIF17 decreases to levels 
measured in untreated cells expressing KIF17 alone (Fig. 3, D 
and E; and Table 1). In contrast, when cells are preincubated on 
ice for 20 min before rewarming in NZ for 45 min, a treatment 
that results in loss of both stable and dynamic MTs in MDCK 
cells (Kreitzer et al., 2003), we measure no difference in EAV or 
the extended population of KIF17 when it is expressed alone 
or coexpressed with EB1 (Fig. 3, D and E). These data indicate 
that the EB1-mediated increase in conformationally extended 
KIF17 is dependent on dynamic MTs and that, in the absence of 
MTs, EB1 cannot recruit/retain KIF17 on MTs and thus cannot 
relieve the autoinhibited state.
In ATPase assays in vitro, EB1 did not affect kcat of 
KIF17M-490 significantly (P > 0.1) but decreased K0.5, MT of 
KIF17M-490 approximately twofold (P < 0.001; Fig. S1 B and 
Table 2), similar to what was shown for kinesin-7 (Tea2) in 
yeast (Browning and Hackney, 2005). In MT-gliding assays, 
EB1 similarly induced a 70% increase in the number of motile 
MTs without changing KIF17M-490 velocity significantly. Col-
lectively, these data suggest EB1 may decrease the off rate of 
KIF17 from MTs and thus retain KIF17 in an extended confor-
mation at dynamic MT ends, promoting MT stabilization.
Active KIF17 is on stable MTs in  
MDCK cells
The constitutively active, extended mutant GFP-KIF17G754E  
accumulates in large puncta at MT plus ends near the cell cortex 
in epithelial cells. This localization is observed even in cells 
treated with NZ to depolymerize dynamic MTs (Jaulin and 
Figure 4. Active KIF17 is on stable MTs in MDCK cells. Box–whisker plots showing the distribution of KIF17 FRETeff (left) and the fraction of active KIF17 
(right) under each experimental condition. Data were obtained from at least three independent experiments ± SEM. Box–whisker plots show minimum, 25th 
percentile, median, 75th percentile, maximum, and mean FRET values.
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where it can participate in MT stabilization and then remain 
on stable MTs. Consistent with this idea, when living cells are 
permeabilized in the presence of AMP-PNP, we detect KIF17-
EmGFP on both unmodified and posttranslationally modified 
MTs (Fig. S3 B). Because the majority of extended conformation 
(Fig. S3 A). Because KIF17G754E remains on MT plus ends in 
the absence of EB1 (Jaulin and Kreitzer, 2010), it is not likely 
that loss of EB1 from MTs in taxol (unpublished data) causes 
the observed changes in KIF17 activity and localization. These 
results suggest KIF17 uses dynamic MTs to reach MT plus ends 
Figure 5. Proposed model for KIF17 in MT stabilization in 
epithelial cells. (1) KIF17 is found in the compact, autoinhib-
ited conformation in MDCK cells. After activation, through 
a pathway involving PKC, KIF17 is activated for binding to 
MTs. (2) KIF17 binds dynamic MTs and reaches MT plus 
ends where it interacts with EB1. Interaction with EB1 pro-
motes KIF17 accumulation at MT plus ends. (3) KIF17 is 
captured at the cortex by an as yet unidentified stabilization 
factor either directly, via EB1, or via another cargo. Alter-
natively, KIF17 may stabilize MTs by accumulating at plus 
ends and inhibiting turnover of tubulin subunits. (4) KIF17 
remains at plus ends of stabilized MTs but cannot bind to 
stable MTs de novo. Ace, acetylated; Tyr, tyrosinated.
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for figure assembly. Images shown in Fig. S3 B were also enhanced using 
the unsharp mask feature in MetaMorph (kernel size = 3, scaling factor = 
0.85, and result scale = auto).
Fluorescence lifetime imaging
All FLIM experiments were performed in The Rockefeller University Bio-
Imaging Resource Center in New York, NY. To perform FLIM, cells were 
transferred to recording medium (Hank’s balanced salt solution with 10 mM 
Hepes, 1% FBS, 4.5 g/liter glucose, and essential and nonessential amino 
acids) and incubated at 37°C in a stage top incubator (INU series; Tokai 
Hit Co., Ltd.). The experiments were performed on a Nikon TiE using a 
40× Plan Apochromat oil immersion objective (NA 1.3) and a fre-
quency domain lifetime attachment (Lambert Instruments) controlled by the 
vendor’s LI-FLIM software. EmGFP was excited with 4 mW of light from 
a 488-nm light-emitting diode, modulated at 40 MHz, and emission was 
collected using a 510–560-nm electromagnetic filter, with an intensified 
charge-coupled device (10.3-µm pixels; LI2CAM; Lambert Instruments). A 
reference lifetime of 4.0 ns was determined from a 1-µM solution of fluor-
escein in saline.
Expression constructs
KIF17 and EB1 were amplified by PCR from human A549 or Caco2 cells 
and cloned into the p201DONR (Gateway; Invitrogen) vector (Jaulin and 
Kreitzer, 2010). We engineered the FRET expression vector by modify-
ing pDEST-monomeric mCh-C1a (Invitrogen) to include EmGFP (monomeric 
EmGFP) at the C terminus. DNA encoding KIF17 sequences were intro-
duced by recombination with LR Clonase as recommended (Invitrogen), 
resulting in constructs with mCh (acceptor) and EmGFP (donor) fused to 
the N and C termini of kinesin, respectively, with a 10–amino acid linker 
between the tags and the kinesin. A previous study in COS cells suggested 
that large epitope tags connected to kinesins via short linkers to the N 
(4 amino acids) or C (10 amino acids) termini of KIF17 could interfere 
with conformational regulation of the protein (Hammond et al., 2010). 
Therefore, we also tested constructs with long linkers in our experiments. 
For all of these (≤30 amino acids), we saw no loss of MT association or 
significant difference in KIF17 activity by FLIM.
Constructs and protein purification
Recombinant, functional mCh-KIF17-EmGFP (or any version of full-length 
KIF17) could not be purified in sufficient quantities in any host system 
tested. Therefore, we instead generated a C-terminally truncated protein 
encoding KIF17M-490 (amino acids 1–490) containing the motor, neck, 
and first coiled-coil domains of KIF17 for analysis in vitro. The in vitro 
activity of KIF17M-490 was identical to a version of the protein lacking the 
first coiled coil (KIF17M-370). KIF17M-490 was amplified by PCR from full-
length human KIF17 described in Jaulin and Kreitzer (2010) and cloned 
into p201DONR (Invitrogen) as described for biosensor constructs. The 
forward primer used to generate KIF17M-490 was 5-GGGGACAAGTT-
TGTACAAAAAAGCAGGCTTCATGGCCTCCGAGGCGGTGAA-3; the 
reverse primer was 5-GGGGACCACTTGTACAAGAAAGCTGGGTCCTA-
AAAAGCAGGCGGGTACTCAGC-3. All N-terminal GST fusions were 
generated by recombination of with LR Clonase into pDEST27 (Invitrogen). 
GST-KIF17 tail domain (tail 849–1,029 amino acids) and full-length GST-
EB1 constructs in pDEST27 were described previously (Jaulin and Kreitzer, 
2010). GST fusions were transformed into Escherichia coli BL21-DE3 cells, 
and protein expression was induced by addition of 1 mM IPTG for 4 h 
before harvesting cells. GST fusions were immobilized on glutathione– 
Sepharose 4B (GE Healthcare) for affinity purification. For motor domain 
constructs, additional purification on anion exchange chromatography (for 
motor domain; Q Sepharose Fast Flow; Sigma-Aldrich) was required to 
remove contaminating bands. Purified proteins were dialyzed and stored 
in 80 mM K-Pipes, 100 mM KCl, 2 mM MgCl2, and 1 mM EGTA, pH 6.9, 
with 5% glycerol and 0.5 mM DTT. Purified motor domain was stored at 
>1.5 mg/ml with 50 µM ATP. Protein concentrations were determined by 
Bradford assay and are reported as monomer concentration if not other-
wise stated.
Tubulin purification. Tubulin was purified from bovine brain by two 
cycles of temperature-dependent assembly and disassembly followed by 
chromatography over DEAE-Sephadex (Sigma-Aldrich) as previously de-
scribed (Borisy et al., 1975). In brief, tubulin was polymerized from brain 
homogenates in PEM (80 mM Pipes-K, pH 6.8, 1 mM EGTA, and 1 mM 
MgCl2) supplemented with 0.1 mM GTP and 10% glycerol at 37°C, and 
assembled MTs were pelleted by centrifugation. The supernatant was re-
moved, and MTs were dissociated in cold PEM containing 1 mM GTP and 
centrifuged at 4°C to remove aggregated protein. MT-associated proteins 
KIF17 resides on stable MTs and because we measure no change 
in EAV or extended mCh-KIF17-EmGFP when dynamic MTs are 
depolymerized selectively, we speculate that the pool of KIF17 
being activated on dynamic MTs is small and, thus, below our 
detection limit with FRET analysis.
Together, our data support a model (Fig. 5) wherein 
KIF17 is activated through a pathway involving PKC that in-
duces a conformational change sufficient for binding to MTs. 
Next, motile KIF17 interacts with EB1 at dynamic MT plus 
ends, inducing accumulation of activated motor at these sites. 
Activated KIF17 at MT plus ends could potentially interact di-
rectly, or through a cargo, with cortical factors involved in reg-
ulating MT stability, forming a “stable” bridge between MTs 
and the cortex. Alternatively, KIF17 could protect MT ends in-
dependent of cargo or cortical factors. Indeed, we find that the 
KIF17 motor domain is sufficient to protect MTs from depoly-
merization in vitro (Acharya et al., 2013). Further studies ex-
ploring these important questions are underway. The results of 
this work provide novel mechanistic insight into how KIF17 
participates in MT stabilization in epithelial cells. In addition, 
these studies demonstrate that kinesin biosensors, monitored 
by FLIM in living cells and analyzed on phasor plots, can be 
applied widely to study kinesin regulation and to identify phys-
iologically relevant factors that modify kinesin conformation 
and activity in vivo.
Materials and methods
Cell culture, transfection, and microinjection
MDCK cells were cultured in DMEM (4.5 g/liter glucose) with 5% FBS and 
20 mM Hepes, pH 7.2. MDCK cells were seeded on sterilized coverslips 
and used at 80% confluence 2–3 d after plating. Transfections (5 µg DNA) 
were performed using a nucleofector (Amaxa; Lonza) as recommended. 
Microinjection was performed essentially as described previously (Jaulin 
et al., 2007). 5–20 µg/ml cDNAs in HKCl (10 mM Hepes and 140 mM KCl, 
pH 7.4) were pressure injected using a micromanipulator (MMO-202ND; 
Narishige). Cells were incubated at 37°C for 60–90 min to allow for ex-
pression of cDNAs. NZ and taxol were purchased from Sigma-Aldrich. OA 
was obtained from EMD Millipore. For FLIM, we analyzed only cells ex-
pressing the biosensor at low to medium levels (less than or equal to mean 
integrated fluorescence intensity/cell of all expressing cells) as there was 
no significant difference in FRET efficiency or the population of compact 
and extended KIF17 under these conditions (low expression, EAV = 7.2 ± 
0.3% and extended population = 25.4 ± 2.4%; mean/medium expres-
sion, EAV = 7.2 ± 0.2% and extended population = 22.2 ± 1.9%). Immuno-
blots showed that biosensor expression is four to five times above levels of 
endogenous KIF17.
Immunofluorescence staining
Cells were fixed in 20°C methanol for 1–2 min. Antibodies used were 
mouse antiacetylated tubulin (611B1; Sigma-Aldrich), rat antityrosinated 
tubulin (YL1/2), and rabbit antidetyrosinated (Glu) tubulin (SG). Fluores-
cently conjugated secondary antibodies (aminomethylcoumarin acetate, 
FITC, Cy3, and Cy5) were obtained from Jackson ImmunoResearch Labo-
ratories, Inc.
Fixed-cell imaging
Fixed-cell images were acquired using E400 or TiE microscopes (Nikon) 
with 40× (NA 1.0), 60×, or 100× (NA 1.4) Plan Apochromat oil immer-
sion objectives and collected with digital charge-coupled device cameras 
(6.45-µm pixels, 1 MHz for 14-bit images [ORCA II-ER; Hamamatsu Photo-
nics] or 6.45-µm pixels, 560 MHz for 16-bit images [Neo sCMOS; Andor 
Technology]). Devices were controlled by either MetaMorph (Molecular 
Devices) or Elements (Nikon). 14–16-bit images were scaled linearly to 
subtract background (noncell fluorescence) and highlight features of inter-
est as indicated in the Results and discussion and converted to 8-bit copies 
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The phasor corresponding to quenched EmGFP is calculated according to 
the last equation. The curved trajectory on the phasor plot represents real-
izations of all possible phasors quenched with different efficiencies.
Circles on the phasor plot include the majority (>95%) of donor pha-
sors. The radius (extending to 7% FRET efficiency here) determines the 
confidence limit for FRET analysis (Caiolfa et al., 2007; Barreiro et al., 
2008). Two phasor subsets are shown in the plots, and corresponding pix-
els are mapped in the FLIM images: pixels highlighted by the red mask 
have FRET efficiency <7% and represent KIF17 in the extended or active 
form, and pixels highlighted by the green mask have FRET efficiency be-
tween 7–21% and represent KIF17 in the compact, inactive conformation. 
FRET efficiency is obtained by localizing the positions of phasor clusters in 
the phasor plot. The position of the measured point on the trajectory gives 
the FRET efficiency. Because the fluorescence decay in each pixel of the 
image gives a point in the phasor plot, the location of the measured point 
is the intensity-weighted mean of FRET, non-FRET, and autofluorescent com-
ponents. Thus, for each pixel in which the contribution of the non-FRET 
component is high (i.e., autofluorescence), points on the phasor plot will 
approach the green line (representing 0% FRET efficiency). Conversely, in 
pixels in which the contribution of the FRET component is high, points on 
the phasor plot approach the red line (representing 50% FRET efficiency) 
following the black trajectory. Because expressed mCh-KIF17-EmGFP is 
primarily soluble, we expect a FRET contribution in each pixel and thus 
each point on the phasor plot. As such, active and inactive KIF17 popula-
tions do not segregate into distinct peaks. In most cases, some points on the 
phasor spread outside the circle of confidence and are not used to deter-
mine fractions of active and inactive KIF17. Thus, active plus inactive 
KIF17 populations do not generally add up to 100%.
Online supplemental material
Fig. S1 shows characterization of KIF17 for FLIM. Fig. S2 shows that 
selective depolymerization of stable MTs with OA results in loss of active 
KIF17. Fig. S3 shows that KIF17 localizes on dynamic and stable MTs in 
MDCK cells. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201305023/DC1.
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